FDA Approves Narcan OTC, Competition and Medicare Reform Discussed 00:10:00
Clayton, Dubilier & Rice, a private investment firm, has named Anand Shah, M.D. as an operating advisor to the firm’s funds. Shah is a former U.S. Food and Drug Administration deputy commissioner for medical and scientific affairs. Going forward, Shah will work with the firm’s healthcare team for new investments and advise the funds’ healthcare businesses. While working with the federal government Shah led bringing new technologies to market, redesigning health care delivery and economics and expanding competition.
